KATRUKHA, ALEXEY G.,POSTNIKOV, ALEXANDER B.,SMOLYANOVA, TATIANA I.,KHARITONOV, ALEXEY V.,TAMM, NATALIA N.
申请号：
EP12770850
公开号：
EP2697654A4
申请日:
2012.04.13
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The method that the method that the present invention describes determines the risk of following serious adverse cardiac events, proteolytic fragments IGFBP-4 or IGFBP-5 (insulin-like growth factor binding protein 4 or insulin-like growth factor binding protein 5) including detection are in blood samples of patients. The present invention provides antibody and immunoassay to say, is suitable for the proteolytic fragments of particular measurement IGFBPs. In the present invention, the IGFBP segments are proposed as the main adverse cardiac events of blood biomarker risk prediction (MACE).
